Hypoglycemia
Combination insulin icodec and semaglutide cuts HbA1c and body weight in type 2 diabetes
Once-weekly combination therapy of basal insulin icodec and semaglutide was noninferior to insulin glargine plus insulin aspart for lowering HbA1c among adults with type 2 diabetes, according to topline results from a phase 3a trial.
Q&A: Increased awareness may boost uptake of inhaled insulin
A form of inhaled insulin has been available for adults with type 1 and type 2 diabetes for nearly a decade, but providers say many people are not aware that it may be a treatment option for them.
About 40% of patients with type 2 diabetes discontinue second-line medication
Almost 40% of patients with type 2 diabetes stopped taking their second-line medication within 1 year, putting them at risk for future hospitalization related to diabetes, according to researchers.
Obesity management, teplizumab guidance among updates in ADA 2024 Standards of Care
New guidance on obesity management and cardiovascular disease screening for people with diabetes are among the updates in the American Diabetes Association’s 2024 Standards of Care.
Glycemia Risk Index bests time in range in assessing hypoglycemia for adults with diabetes
The new continuous glucose monitoring metric Glycemia Risk Index better assesses hypoglycemia risk than time in range, according to study data.
Hybrid closed-loop system lowers severe hypoglycemia, DKA rates in type 1 diabetes
Children and adults using a hybrid closed-loop insulin delivery system had fewer cases of severe hypoglycemia and diabetic ketoacidosis than what was previously observed in historical data, according to study findings.
FDA warns people with diabetes to avoid product sold for blood glucose management
The FDA issued a warning for consumers to avoid using a nonprescription product currently being sold for blood glucose management due to risks for adverse events, according to an agency press release.
Most adults with diabetes report emotional distress, but do not discuss it with care team
The majority of adults with diabetes say their diabetes team has never discussed the topic of mental health with them, even though most self-reported feelings of emotional distress, according to survey data published in Diabetic Medicine.
FDA updates Ozempic label to include warning for intestinal blockage, hypoglycemia risk
The FDA has updated the label for Ozempic to include the potential risk for ileus, or an intestinal blockage, as well as increased risk for hypoglycemia if used in combination with insulin or insulin secretagogue.
Diabetes distress worse among adults with impaired hypoglycemia awareness
Adults with type 1 diabetes and impaired awareness of hypoglycemia have worse diabetes-related distress than those with normal hypoglycemia awareness, according to a study published in Diabetic Medicine.